Trial
NCT03234309
Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
AMAG Pharmaceuticals, Inc.; Oregon Health and Science University
Condition
Brain Neoplasm
Intervention
Ferumoxytol
Why stopped
No enrollments
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-10